BioSpace News Archive

As Deadliest Strain Ravages Country, Four Experimental Ebola Vaccines to Be Deployed in the Congo

As an outbreak of the Ebola virus in the Democratic Republic of the Congo worsens, a team of health officials has taken four experimental vaccines to the front lines and begun to administer it to patients who may have been exposed to the deadly virus.

November 12, 2018
·
3 min read
·
Alex Keown
Career Advice

Resume Best Practices: 4 Things You Should Always Include in Your Employment History Section

Your employment or work history section of your resume is likely the single most important category in the entire document and, when done well, can make a powerful case to your potential employer about how and why you’re well qualified for their open position.

November 12, 2018
·
3 min read
·
Editorial Staff
Drug Development

Melinta Therapeutics Announces Positive Top-Line Results in Phase III Trial of Baxdela® (delafloxacin) for Treatment of CABP

Met primary endpoint of Early Clinical Response at 96 hours after the first dose

November 12, 2018
·
13 min read
Lamellar to introduce its LAMELLASOME™ technology for the safe and effective delivery of nucleic acid based therapeutics at BIO-Europe 2018 in Copenhagen

Lamellar Biomedical Limited announces that Dr Alec McLean ,CEO, Dr Lynsey Howard (Head of Preclinical) and Steven Porteous (Head of Clinical and Regulatory) will be attending BIO-Europe 2018 in Copenhagen to introduce potential partners and investors to its cutting-edge LAMELLASOME™ technology.

November 12, 2018
·
3 min read
IVI MIDDLE EAST FERTILITY CLINIC IN MUSCAT UNVEILS LIMITED SPECIAL OFFER TO CELEBRATE OMANI WOMEN’S DAY

In commemoration of Omani Women’s Day (Wednesday, October 17, 2018), IVI Middle East Fertility Clinic in Muscat has unveiled a special offer paying tribute to women and their important role in nation building.

November 12, 2018
·
1 min read
Business

MorphoSys to Host Q3 2018 Conference Call on November 6, 2018

MorphoSys AG will publish its third quarter 2018 results on November 5, 2018 at 10:00pm CET (9:00pm GMT; 4:00pm EST).

November 12, 2018
·
4 min read
Business

Registration is Live for World’s Largest Advanced Therapies and Stem Cell Event with 2,000 Attendees Expected at Hyatt Regency Miami in January 2019

Early Bird Rate Ends November 15th, 2018!

November 12, 2018
·
5 min read
Drug Development

THERANEXUS ANNOUNCES INCLUSION OF LAST PATIENT IN PHASE II TRIAL OF DRUG CANDIDATE THN102 ON NARCOLEPSY PATIENTS

Theranexus announces today that it has recruited the last patient in its Phase II trial, entitled “Tolerance and Efficacy of THN102 on Sleepiness in Narcoleptic Patients”.

November 12, 2018
·
2 min read
Policy

U.S. EPA settles with two California companies for failure to provide required toxic chemical notifications

The U.S. Environmental Protection Agency (EPA) has settled with two California companies for failing to provide required notifications for the handling of toxic chemicals.

November 12, 2018
·
1 min read
LUCENCE DIAGNOSTICS LAUNCHES WORLD’S FIRST MOLECULAR TEST TO GUIDE SURGICAL APPROACH FOR BREAST FIBROEPITHELIAL TUMORS

Lucence Diagnostics today announced the launch of the world’s first molecular test to distinguish breast fibroadenoma, the commonest benign breast tumor, from phyllodes tumor, a less common tumor that may be malignant.

November 12, 2018
·
6 min read